Targeting CDK9 for treatment of colorectal cancer

Colorectal cancer (CRC) remains one of the most lethal human malignancies, and pursuit of new therapeutic targets for treatment has been a major research focus. Cyclin‐dependent kinase 9 (CDK9), which plays a crucial role in transcription, has emerged as a target for cancer treatment. CDKI‐73, one o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahaman, Muhammed H., Lam, Frankie, Zhong, Longjin, Teo, Theodosia, Adams, Julian, Yu, Mingfeng, Milne, Robert W., Pepper, Chris, Lokman, Noor A., Ricciardelli, Carmela, Oehler, Martin K., Wang, Shudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763784/
https://www.ncbi.nlm.nih.gov/pubmed/31398271
http://dx.doi.org/10.1002/1878-0261.12559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763784/
https://www.ncbi.nlm.nih.gov/pubmed/31398271
http://dx.doi.org/10.1002/1878-0261.12559

Ejemplares similares